Pharmacology, 11th Edition Linda E. McCuistion Kathleen Vuljoin DiMaggio Mary B. Winton Jennifer J. Yeager, 2023 Test bank

Table of Contents for Pharmacology Test bank

• Instructions for online access
• Cover image
• Title page
• Table of Contents
• Copyright
• Dedication
• Meet The Authors
• In Recognition
• Contributors
• Reviewers
• Preface
• Acknowledgments
• Unit I. Introduction to Pharmacology
• 1. Clinical Judgment Management Model (CJMM) and the Nursing Process
• Explanation Of Terms
• Clinical Judgment [Nursing Process]
• Recognize Cues [Assessment]
• Analyze Cues [Analysis] and Prioritze Hypothesis [Analysis]
• Generate Solutions [Planning]
• Take Action [Nursing Interventions]
• Evaluate Outcomes [Evaluation]
• 2. Drug Development and Ethical Considerations
• Core Ethical Principles
• Objectives and Phases of Pharmaceutical Research
• American Nurses Association Code of Ethics
• Drug Standards and Legislation
• Nurse Practice Acts
• Canadian Drug Regulation
• Initiatives to Combat Drug Counterfeiting
• Drug Names
• Over-the-Counter Drugs
• Drug Resources
• 3. Pharmacokinetics and Pharmacodynamics
• Pharmacokinetics
• Pharmacodynamics
• Drug Interactions
• Drug-Nutrient Interactions
• Drug-Laboratory Interactions
• Drug-Induced Photosensitivity
• 4. Pharmacogenetics
• Brief History
• Clinical Uses
• Individual Variation In Metabolism of Select Drugs
• Legal and Ethical Issues
• 5. Complementary and Alternative Therapies
• Dietary Supplement Health and Education Act of 1994
• Current Good Manufacturing Practices
• Commonly Used Herbal Remedies
• Potential Hazards of Herbs
• Tips for Consumers and Health Care Providers
• Herbal Resources
• 6. Pediatric Considerations
• Pharmacokinetics
• Pharmacodynamics
• Nursing Implications
• Considerations for the Adolescent Patient
• Family-Centered Collaborative Care
• 7. Drug Therapy in Older Adults
• Physiologic Changes
• Pharmacokinetics
• Pharmacodynamics
• Nursing Implications: Older Adult Drug Dosing and Monitoring
• Health Teaching With the Older Adult
• 8. Drugs in Substance Use Disorder
• Substance Use Disorder
• Special Needs of Patients With Substance Use Disorder
• The Nurse With Substance Use Disorder
• Unit II. Pharmacotherapy and Drug Administration
• 9. Safety and Quality
• Quality and Safety Education for Nurses
• “Six Rights” of Medication Administration
• Just and Safe Culture
• Safety Risks with Medication Administration
• Pregnancy Categories and Subsections
• Guidelines for Medication Administration
• 10. Drug Administration
• Forms and Routes of Drug Administration
• Nursing Implications for Administration of Parenteral Medications
• Developmental Needs of a Pediatric Patient
• 11. Drug Calculations
• Systems of Measurement and Conversion Factors
• Interpreting Drug Labels
• Precautions When Reading Drug Labels
• Drug Reconstitution
• Calculation Methods
• Considerations for Enteral Administration
• Considerations for Parenteral Administration
• Calculating Intravenous Flow Rate: Drops Per Minute
• Calculating Intravenous Flow Rate: Milliliters Per Hour
• Answers to Practice Problems
• Unit III. Maintenance of Homeostasis
• 12. Fluid Volume and Electrolytes
• Homeostasis
• Fluid Replacement
• 13. Vitamin and Mineral Replacement
• Vitamins
• Minerals
• 14. Nutritional Support
• Different Types of Nutritional Support
• Unit IV. Autonomic Nervous System Drugs
• 15. Adrenergic Agonists and Antagonists
• Sympathetic Nervous System
• Adrenergic Agonists
• Central-Acting Alpha Agonists
• Adrenergic Antagonists (Adrenergic Blockers)
• 16. Cholinergic Agonists and Antagonists
• Parasympathetic Nervous System
• Cholinergic Agonists
• Cholinergic Antagonists
• Unit V. Central and Peripheral Nervous System Drugs
• 17. Stimulants
• Pathophysiology
• Amphetamines
• Anorexiants and Analeptics
• 18. Depressants
• Types and Stages of Sleep
• Nonpharmacologic Methods
• Sedative-Hypnotics
• Anesthetics
• 19. Antiseizure Drugs
• International Classification of Seizures
• Antiseizure Drugs
• 20. Drugs for Parkinsonism and Alzheimer Disease
• Parkinson Disease
• Alzheimer Disease
• 21. Drugs for Neuromuscular Disorders and Muscle Spasms
• Myasthenia Gravis
• Multiple Sclerosis
• Skeletal Muscle Relaxants
• Unit VI. Mental and Behavioral Health Drugs
• 22. Antipsychotics and Anxiolytics
• Introduction
• Psychosis
• Antipsychotic Agents
• Anxiolytics
• 23. Antidepressants and Mood Stabilizers
• Depression
• Antidepressant Agents
• Mood Stabilizers
• Unit VII. Pain and Inflammation Management Drugs
• 24. Antiinflammatories
• Introduction
• Pathophysiology
• Antiinflammatory Agents
• Nonsteroidal Antiinflammatory Drugs
• Corticosteroids
• Disease-Modifying Antirheumatic Drugs
• Antigout Drugs
• 25. Analgesics
• Pathophysiology
• Nonopioid Analgesics
• Opioid Analgesics
• Adjuvant Therapy
• Treatment for Substance Use Disorder
• Opioid Agonist-Antagonists
• Opioid Antagonists
• Headaches: Migraine and Cluster
• Unit VIII. Antimicrobial Drugs
• 26. Penicillins, Other Beta-Lactams, and Cephalosporins
• Introduction
• Pathophysiology
• Antibacterial Drugs
• Penicillins and Cephalosporins
• Other Beta-Lactam Antibacterials
• Cephalosporins
• 27. Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, and Lipopeptides
• Introduction
• Macrolides
• Oxazolidinones
• Lincosamides
• Glycopeptides
• Ketolides
• Lipopeptides
• 28. Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones
• Introduction
• Tetracyclines
• Glycylcyclines
• Aminoglycosides
• Fluoroquinolones (Quinolones)
• 29. Sulfonamides and Nitroimidazoles Antibiotics
• Introduction
• Sulfonamides
• Nitroimidazoles
• Miscellaneous Antibacterial Drugs (Table 29.3)
• 30. Antituberculars, Antifungals, and Antivirals
• Tuberculosis
• Antitubercular Drugs
• Special Populations
• Fungus
• Antifungal Drugs
• Viruses
• Non-HIV Antivirals
• 31. Antimalarials, Anthelmintics, and Peptides
• Antimalarial Drugs
• Anthelmintic Drugs
• Peptides
• Unit IX. Immunologic Drugs
• 32. HIV- and AIDS-Related Drugs
• HIV Infection: Pathophysiology
• HIV Transmission
• Laboratory Testing
• Classification
• Indications for Antiretroviral Therapy
• Antiretroviral Drugs
• Immune Reconstitution Inflammatory Syndrome
• The Nurse’s Role in Antiretroviral Therapy
• Opportunistic Infections
• Antiretroviral Therapy in Pregnancy
• Occupational HIV Exposure and Postexposure Prophylaxis
• 33. Transplant Drugs
• Organ Transplantation
• Promoting Adherence
• 34. Vaccines
• Immunity
• Vaccines
• Vaccine-Preventable Diseases
• Vaccination Recommendations
• Immunization Before International Travel
• Vaccine Safety: Reporting Diseases and Adverse Reactions
• Varicella Vaccine
• Future Developments in Vaccines
• Unit X. Antineoplastics and Biologic Response Modifiers
• 35. Anticancer Drugs
• Genetic, Inflammatory, Infective, Environmental, and Dietary Influences
• Cell Cycle–Nonspecific and Cell Cycle–Specific Anticancer Drugs
• Cancer Chemotherapy
• Alkylating Drugs
• Antimetabolites
• Antitumor Antibiotics
• Plant Alkaloids
• Immunomodulators
• Targeted Therapies
• Liposomal Chemotherapy
• Hormones and Hormonal Agonists and Antagonists
• Biologic Response Modifiers
• Miscellaneous Chemotherapy Agents
• Vaccines
• 36. Targeted Therapies to Treat Cancer
• Targeted Therapy Drugs
• 37. Biologic Response Modifiers
• Interferons
• Colony-Stimulating Factors
• Interleukin 2
• Unit XI. Respiratory Drugs
• 38. Upper Respiratory Disorders
• Introduction
• Common Cold, Acute Rhinitis, and Allergic Rhinitis
• Sinusitis
• Acute Pharyngitis
• Critical Thinking Case Study
• Review Questions
• 39. Lower Respiratory Disorders
• Introduction
• Lung Compliance
• Control of Respiration
• Bronchial Smooth Muscle
• Chronic Obstructive Pulmonary Disease
• Sympathomimetics: Alpha- and Beta2-Adrenergic Agonists
• Anticholinergics
• Methylxanthine (Xanthine) Derivatives
• Leukotriene Receptor Antagonists and Synthesis Inhibitors
• Glucocorticoids (Steroids)
• Cromolyn
• Drug Therapy for Asthma According to Severity
• Drug Therapy for Asthma according to Age
• Antimicrobials
• Unit XII. Cardiovascular Drugs
• 40. Cardiac Glycosides, Antianginals, and Antidysrhythmics
• Introduction
• Heart
• Conduction of Electrical Impulses
• Regulation of Heart Rate and Blood Flow
• Circulation
• Blood
• Laboratory Tests to Diagnose Heart Failure
• Nonpharmacologic Measures to Treat Heart Failure
• Agents Used To Treat Heart Failure
• Antianginal Drugs
• Antidysrhythmic Drugs
• 41. Diuretics
• Thiazides and Thiazide-Like Diuretics
• Loop Diuretics
• Osmotic Diuretics
• Carbonic Anhydrase Inhibitors
• Potassium-Sparing Diuretics
• 42. Antihypertensives
• Hypertension
• Nonpharmacologic Control of Hypertension
• Pharmacologic Control of Hypertension
• 43. Anticoagulants, Antiplatelets, and Thrombolytics
• Pathophysiology: Thrombus Formation
• Anticoagulants
• Antiplatelet Drugs
• Thrombolytics
• 44. Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow
• Lipoproteins
• Apolipoproteins
• Nonpharmacologic Methods of Cholesterol Reduction
• Antihyperlipidemics
• Drugs to Improve Peripheral Blood Flow
• Unit XIII. Gastrointestinal Drugs
• 45. Gastrointestinal Tract Disorders
• Overview of the Gastrointestinal System
• Drugs for Gastrointestinal Disorders
• Vomiting
• Emetics
• Diarrhea
• Constipation
• 46. Antiulcer Drugs
• Predisposing Factors in Peptic Ulcer Disease
• Nonpharmacologic Measures for Managing Peptic Ulcer and Gastroesophageal Reflux Disease
• Antiulcer Drugs
• Unit XIV. Eye, Ear, and Skin Drugs
• 47. Eye and Ear Disorders
• Overview of the Eye
• Drugs for Disorders of the Eye
• Overview of the Ear
• Drugs for Disorders of the Ear
• 48. Dermatologic Disorders
• Overview of the Skin
• Acne Vulgaris
• Psoriasis
• Verruca Vulgaris (WARTS)
• Drug-Induced Dermatitis
• Contact Dermatitis
• Impetigo
• Rosacea
• Hair Loss and Baldness
• Sunscreens
• Burns and Burn Preparations
• Unit XV. Endocrine Drugs
• 49. Pituitary, Thyroid, Parathyroid, and Adrenal Disorders
• Pituitary Gland
• Thyroid Gland
• Parathyroid Glands
• Adrenal Glands
• 50. Antidiabetics
• Introduction
• Diabetes Mellitus
• Unit XVI. Renal and Urologic Drugs
• 51. Urinary Disorders
• Introduction
• Urinary Antiseptics/Antiinfectives and Antibiotics
• Urinary Analgesics
• Urinary Stimulants
• Urinary Antispasmodics/Antimuscarinics/Anticholinergics
• Unit XVII. Reproductive and Gender-Related Drugs
• 52. Pregnancy and Preterm Labor
• Physiology of Pregnancy
• Therapeutic Drugs and Use of Herbs in Pregnancy
• Drugs That Decrease Uterine Muscle Contractility
• Corticosteroid Therapy in Preterm Labor
• Drugs for Gestational Hypertension
• 53. Labor, Delivery, and Postpartum
• Drugs For Pain Control During Labor
• Drugs That Enhance Uterine Muscle Contractility
• Drugs Used During the Postpartum Period
• Immunizations
• Postpartum Depression
• 54. Neonatal and Newborn
• Drugs Administered to Preterm Neonates
• Drugs Administered to Full-Term, Healthy Neonates
• 55. Women’s Reproductive Health
• Drugs Used for Contraception
• Drugs Used to Treat Disorders in Women’s Health
• Drugs Used to Promote Fertility
• Menopause
• 56. Men’s Reproductive Health
• Drugs Related to Male Reproductive Disorders
• 57. Sexually Transmitted Infections
• Sexually Transmitted Infections
• Sexually Transmitted Pathogens
• Prevention of Sexually Transmitted Infections
• Unit XVIII. Adult and Pediatric Emergency Drugs
• 58. Adult and Pediatric Emergency Drugs
• Introduction
• Oxygen as an Emergency Drug
• Emergency Drugs For Cardiac Disorders
• Emergency Drug For Intracranial Hypertension
• Emergency Drugs For Drug Overdose
• Emergency Drugs For Shock
• Emergency Drugs for Hypertensive Crises
• Appendix A. Answers to Review Questions
• Appendix B. Solution Compatibility Chart
• Appendix C. Immunizations
• Bibliography
• Glossary
• Index